[HTML][HTML] Molecular epidemiology of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology–mainland China subset …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li, G Wu… - PloS one, 2015 - journals.plos.org
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
[引用][C] Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology-Mainland China …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li… - PLoS …, 2015 - ui.adsabs.harvard.edu
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell
Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the …
Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the …
[PDF][PDF] Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology–Mainland China …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li - PLoS ONE, 2015 - scienceopen.com
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
[PDF][PDF] Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology–Mainland China …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li - PLoS ONE, 2015 - pdfs.semanticscholar.org
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
[引用][C] Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology–Mainland China …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li, G Wu… - PLOS ONE, 2015 - cir.nii.ac.jp
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell
Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER …
Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER …
[HTML][HTML] Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology–Mainland China …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li, G Wu… - PLoS ONE, 2015 - ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology-Mainland China Subset …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li, G Wu… - PLoS ONE, 2015 - go.gale.com
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology-Mainland China Subset …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li, G Wu… - Plos one, 2015 - europepmc.org
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology–Mainland China Subset …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li… - PLoS …, 2015 - search.ebscohost.com
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology-Mainland China Subset …
Y Shi, J Li, S Zhang, M Wang, S Yang, N Li… - PloS …, 2015 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) mutations are the strongest response predictors to
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …
EGFR tyrosine kinase inhibitors (TKI) therapy, but knowledge of the EGFR mutation …